Role of IL-23 neutralization in psoriasis: insights from a mechanistic PK/PD model and meta-analysis of clinical data
Kapitanov, G. I.
Show abstract
Blocking of IL-23 has shown a profound effect on patient outcomes in psoriasis. The current IL-23 binding monoclonal antibodies show differences in dosing regimens, pharmacokinetics, affinity for the target, and efficacy outcomes in the clinic. The goal of the current work is to use a mechanistic pharmacokinetics/pharmacodynamics mathematical model to estimate projected free IL-23 neutralization for the different therapeutic molecules and connect it to clinical efficacy outcomes. The meta-analysis indicates a sigmoid-like relationship and suggests that the best current anti-IL23 antibodies are close to saturating the efficacy that can be achieved by this pathway in psoriasis.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease 92%
- A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosis 91%
- MTXPK.org: A clinical decision support tool evaluating high-dose methotrexate pharmacokinetics to inform post-infusion care and use of glucarpidase 90%
Similar papers in this journal
- A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with BRAF/MEK-inhibitors evidenced by an algorithm-defined pyrexia score 92%
- Imbalanced Machine Learning Classification Models For Removal Biosimilar Drugs And Increased Activity In Patients With Rheumatic Diseases 91%
- DigiLoCS: A Leap Forward in Predictive Organ-on-Chip Simulations 90%
Similar papers in this journal
Similar papers in this journal
- A long-acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese non-human primate model 90%
- A Strategy to Treat COVID-19 Disease with Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Non-clinical Pharmacokinetic Study 89%
- In silico PK predictions in Drug Discovery: Benchmarking of Strategies to Integrate Machine Learning with Empiric and Mechanistic PK modelling 89%
Similar papers in this journal
- Sensitivity of Estimated Tacrolimus Population Pharmacokinetic Profile to Inaccurate Assumptions about Dose Timing and Absorption: An Investigation in Real-World and Simulated Data 93%
- Investigation on the interaction between nifedipine and ritonavir containing antivirus regimens: a physiologically-based pharmacokinetic/pharmacodynamic analysis 90%
- Population Pharmacokinetic Analysis of Dexmedetomidine in Children using Real-World-Data Obtained from Electronic Health Records and Remnant Clinic Samples 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.